Mostly Supported — Selank: Selank reduces anxiety

Selank is a synthetic peptide developed in Russia that has shown promise in reducing symptoms of generalized anxiety disorder (GAD) and various phobic-anxiety disorders in human studies. It appears to work by modulating enkephalin activity and resting-state brain connectivity. While the evidence is positive, most research originates from a single region and involves small patient groups, which limits generalizability.